Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling

被引:242
作者
Eklund, L [1 ]
Olsen, BR [1 ]
机构
[1] Harvard Univ, Sch Dent Med, Dept Oral & Dev Biol, REB, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
angiopoietin; Tie1; Tie2; endothelial cell; mural cell; blood vessel; angiogenesis;
D O I
10.1016/j.yexcr.2005.09.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Angiopoietins are ligands of the Tie2 receptor that control angiogenic remodeling in a context-dependent manner. Tie signaling is involved in multiple steps of the angiogenic remodeling process during development, including destabilization of existing vessels, endothelial cell migration, tube formation and the subsequent stabilization of newly formed tubes by mesenchymal cells. Beyond this critical role in blood vessel development, recent studies suggest a wider role for Tie2 and angiopoietins in lymphangiogenesis and the development of the hematopoietic system, as well as a possible role in the regulation of certain non-endothelial cells. The outcome of Tie signaling depends on which vascular bed is involved, and crosstalk between different VEGFs has an important modulating effect on the properties of the angiopoietins. Signaling through the Tiel receptor is not well understood, but Tiel may have both angiopoietin-dependent and ligand-independent functions. Changes in the expression of Tie receptors and angiopoietins Occur in many pathological conditions, and mutations in the Tie2 gene are found in familial cases of vascular disease. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:630 / 641
页数:12
相关论文
共 144 条
  • [71] Inhibition of tumor angiogenesis using a soluble receptor establishes a role for Tie2 in pathologic vascular growth
    Lin, PN
    Polverini, P
    Dewhirst, M
    Shan, SQ
    Rao, PS
    Peters, K
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (08) : 2072 - 2078
  • [72] Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo
    Lobov, IB
    Brooks, PC
    Lang, RA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (17) : 11205 - 11210
  • [73] Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
    Maisonpierre, PC
    Suri, C
    Jones, PF
    Bartunkova, S
    Wiegand, S
    Radziejewski, C
    Compton, D
    McClain, J
    Aldrich, TH
    Papadopoulos, N
    Daly, TJ
    Davis, S
    Sato, TN
    Yancopoulos, GD
    [J]. SCIENCE, 1997, 277 (5322) : 55 - 60
  • [74] Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia
    Mandriota, SJ
    Pepper, MS
    [J]. CIRCULATION RESEARCH, 1998, 83 (08) : 852 - 859
  • [75] Marron MB, 2000, ADV EXP MED BIOL, V476, P35
  • [76] Evidence for heterotypic interaction between the receptor tyrosine kinases TIE-1 and TIE-2
    Marron, MB
    Hughes, DP
    Edge, MD
    Forder, CL
    Brindle, NPJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (50) : 39741 - 39746
  • [77] Dok-R plays a pivotal role in angiopoietin-1-dependent cell migration through recruitment and activation of Pak
    Master, Z
    Jones, N
    Tran, J
    Jones, J
    Kerbel, RS
    Dumont, DJ
    [J]. EMBO JOURNAL, 2001, 20 (21) : 5919 - 5928
  • [78] McCarthy MJ, 1999, LAB INVEST, V79, P889
  • [79] Direct chemotactic action of angiopoietin-1 on mesenchymal cells in the presence of VEGF
    Metheny-Barlow, LJ
    Tian, S
    Hayes, AJ
    Li, LY
    [J]. MICROVASCULAR RESEARCH, 2004, 68 (03) : 221 - 230
  • [80] Mochizuki Y, 2002, J CELL SCI, V115, P175